Passa al contenuto
Merck
Tutte le immagini(1)

Documenti fondamentali

MAK390

Sigma-Aldrich

Alpha Galactosidase (α-Gal) Activity Assay Kit (Fluorometric)

sufficient for 100 fluorometric tests

Sinonimo/i:

Alpha-Gal Assay Kit

Autenticatiper visualizzare i prezzi riservati alla tua organizzazione & contrattuali


About This Item

Codice UNSPSC:
12161503

Metodo di rivelazione

fluorometric

Temperatura di conservazione

−20°C

Descrizione generale

Alpha-Galactosidase (α-Gal) hydrolyzes alpha-galactosyl moieties found in glycolipids and glycoproteins. In mammals, a-Gal hydrolyzes poly- and oligosaccharides commonly found in dietary sources that are difficult to digest. Therefore, α-Gal is used in dietary supplements that help to reduce the production of intestinal gases due to consumption of certain foods. It is known total α-Gal activity is due to two major isozymes with unique, yet different thermostability profiles. Alpha-Galactosidase A, is thermolabile and represents approximately 90% of total α-Gal activity. Fabry Disease, a lysosomal disease disorder, is characterized by mutations in alpha-Galactosidase A. These mutations cause abnormal accumulation of glycosphingolipids in lysosomes.

Applicazioni


  • Exploration of mechanism of total triterpenoids from fruits of Chaenomeles speciosa against senescent GES-1 cells induced by D-galactose based on Gln/GLS1/a-KG metabolic axis and mitochondrial apoptosis signaling pathway.: This study investigates the effects of total triterpenoids on senescent GES-1 cells, exploring mechanisms involving the Gln/GLS1/a-KG metabolic axis and mitochondrial apoptosis signaling pathway (He et al., 2024).

  • Diagnosis of Fabry Disease Using Alpha-Galactosidase A Activity or LysoGb3 in Blood Fails to Identify Up to Two Thirds of Female Patients.: This research highlights the limitations of using alpha-galactosidase A activity and LysoGb3 in blood for diagnosing Fabry Disease, especially in female patients (Duro et al., 2024).

  • Pegunigalsidase alfa: a novel, pegylated recombinant alpha-galactosidase enzyme for the treatment of Fabry disease.: This review focuses on Pegunigalsidase alfa, a new pegylated recombinant enzyme for treating Fabry Disease, discussing its efficacy and potential benefits (Germain & Linhart, 2024).

Caratteristiche e vantaggi

The Alpha Galactosidase (α-Gal) Activity Assay Kit:
  • Detection limit: < 0.1μU.
  • Specific: does not detect beta galactosidase activity.

Compatibilità

The kit is suitable for the detection of α-Galactosidase activity in tissue homogenates (kidney, etc.), cell lysates (U937, etc.) and biological fluids (saliva, etc.).

Principio

The Alpha Galactosidase (α-Gal) Activity Assay Kit provides a simple, rapid way to monitor total α-Gal activity in a wide variety of biological samples. In this kit, α-Gal cleaves a synthetic specific substrate releasing a fluorophore, which can be easily quantified (λex = 360 nm/λem = 445 nm). The assay is specific (beta galactosidase activity is not detected), sensitive and can detect as low as 0.1 μU of α-Galactosidase activity.

Codice della classe di stoccaggio

10 - Combustible liquids

Classe di pericolosità dell'acqua (WGK)

WGK 3


Scegli una delle versioni più recenti:

Certificati d'analisi (COA)

Lot/Batch Number

Non trovi la versione di tuo interesse?

Se hai bisogno di una versione specifica, puoi cercare il certificato tramite il numero di lotto.

Possiedi già questo prodotto?

I documenti relativi ai prodotti acquistati recentemente sono disponibili nell’Archivio dei documenti.

Visita l’Archivio dei documenti

Il team dei nostri ricercatori vanta grande esperienza in tutte le aree della ricerca quali Life Science, scienza dei materiali, sintesi chimica, cromatografia, discipline analitiche, ecc..

Contatta l'Assistenza Tecnica.